Alzheimer’s Transgenic Model Is Characterized by Very Early Brain Network Alterations and β-CTF Fragment Accumulation: Reversal by β-Secretase Inhibition

Alzheimer’s disease (AD) is defined by the presence of amyloid-β (Aβ) and tau protein aggregates. However, increasing data is suggesting that brain network alterations rather than protein deposition could account for the early pathogenesis of the disease. In the present study, we performed in vitro...

Full description

Bibliographic Details
Main Authors: Siddhartha Mondragón-Rodríguez, Ning Gu, Frederic Manseau, Sylvain Williams
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-05-01
Series:Frontiers in Cellular Neuroscience
Subjects:
Online Access:http://journal.frontiersin.org/article/10.3389/fncel.2018.00121/full
_version_ 1828825244639428608
author Siddhartha Mondragón-Rodríguez
Siddhartha Mondragón-Rodríguez
Siddhartha Mondragón-Rodríguez
Ning Gu
Ning Gu
Frederic Manseau
Sylvain Williams
author_facet Siddhartha Mondragón-Rodríguez
Siddhartha Mondragón-Rodríguez
Siddhartha Mondragón-Rodríguez
Ning Gu
Ning Gu
Frederic Manseau
Sylvain Williams
author_sort Siddhartha Mondragón-Rodríguez
collection DOAJ
description Alzheimer’s disease (AD) is defined by the presence of amyloid-β (Aβ) and tau protein aggregates. However, increasing data is suggesting that brain network alterations rather than protein deposition could account for the early pathogenesis of the disease. In the present study, we performed in vitro extracellular field recordings in the CA1/subiculum area of the hippocampus from 30 days old J20-TG-AD mice. Here, we found that theta oscillations were significantly less rhythmic than those recorded from control group. In addition, J20 mice displayed significantly less theta-gamma cross-frequency coupling (CFC) as peak modulation indexes for slow (25–45 Hz) and fast (150–250 Hz) gamma frequency oscillations were reduced. Because inhibitory parvalbumin (PV) cells play a vital role in coordinating hippocampal theta and gamma oscillations, whole-cell patch-clamp recordings and extracellular stimulation were performed to access their intrinsic and synaptic properties. Whereas neither the inhibitory output of local interneurons to pyramidal cells (PCs) (inhibitory→PC) nor the excitatory output of PCs to PV cells (PC→PV) differed between control and J20 animals, the intrinsic excitability of PV cells was reduced in J20 mice compared to controls. Interestingly, optogenetic activation of PV interneurons which can directly drive theta oscillations in the hippocampus, did not rescue CFC impairments, suggesting the latter did not simply result from alteration of the underlying theta rhythm. Altered young J20 mice was characterized by the presence of β-CTF, but not with Aβ accumulation, in the hippocampus. Importantly, the β secretase inhibitor AZD3839-AstraZeneca significantly rescued the abnormal early electrophysiological phenotype of J20 mice. In conclusion, our data show that brain network alterations precede the canonical Aβ protein deposition and that, such alterations can be related to β-CTF fragment.
first_indexed 2024-12-12T14:12:17Z
format Article
id doaj.art-bed75123f5b44534817fa6f1f86d485f
institution Directory Open Access Journal
issn 1662-5102
language English
last_indexed 2024-12-12T14:12:17Z
publishDate 2018-05-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cellular Neuroscience
spelling doaj.art-bed75123f5b44534817fa6f1f86d485f2022-12-22T00:22:01ZengFrontiers Media S.A.Frontiers in Cellular Neuroscience1662-51022018-05-011210.3389/fncel.2018.00121353008Alzheimer’s Transgenic Model Is Characterized by Very Early Brain Network Alterations and β-CTF Fragment Accumulation: Reversal by β-Secretase InhibitionSiddhartha Mondragón-Rodríguez0Siddhartha Mondragón-Rodríguez1Siddhartha Mondragón-Rodríguez2Ning Gu3Ning Gu4Frederic Manseau5Sylvain Williams6Department of Psychiatry, Douglas Mental Health University Institute, McGill University, Montreal, QC, CanadaCONACYT National Council for Science and Technology, Mexico City, MexicoUNAM Developmental Neurobiology and Neurophysiology, Institute of Neurobiology, National Autonomous University of Mexico, Querétaro, MexicoDepartment of Psychiatry, Douglas Mental Health University Institute, McGill University, Montreal, QC, CanadaDepartment of Translational Neuroscience, The Royal Mental Health Research Institute, University of Ottawa, Ottawa, ON, CanadaDepartment of Psychiatry, Douglas Mental Health University Institute, McGill University, Montreal, QC, CanadaDepartment of Psychiatry, Douglas Mental Health University Institute, McGill University, Montreal, QC, CanadaAlzheimer’s disease (AD) is defined by the presence of amyloid-β (Aβ) and tau protein aggregates. However, increasing data is suggesting that brain network alterations rather than protein deposition could account for the early pathogenesis of the disease. In the present study, we performed in vitro extracellular field recordings in the CA1/subiculum area of the hippocampus from 30 days old J20-TG-AD mice. Here, we found that theta oscillations were significantly less rhythmic than those recorded from control group. In addition, J20 mice displayed significantly less theta-gamma cross-frequency coupling (CFC) as peak modulation indexes for slow (25–45 Hz) and fast (150–250 Hz) gamma frequency oscillations were reduced. Because inhibitory parvalbumin (PV) cells play a vital role in coordinating hippocampal theta and gamma oscillations, whole-cell patch-clamp recordings and extracellular stimulation were performed to access their intrinsic and synaptic properties. Whereas neither the inhibitory output of local interneurons to pyramidal cells (PCs) (inhibitory→PC) nor the excitatory output of PCs to PV cells (PC→PV) differed between control and J20 animals, the intrinsic excitability of PV cells was reduced in J20 mice compared to controls. Interestingly, optogenetic activation of PV interneurons which can directly drive theta oscillations in the hippocampus, did not rescue CFC impairments, suggesting the latter did not simply result from alteration of the underlying theta rhythm. Altered young J20 mice was characterized by the presence of β-CTF, but not with Aβ accumulation, in the hippocampus. Importantly, the β secretase inhibitor AZD3839-AstraZeneca significantly rescued the abnormal early electrophysiological phenotype of J20 mice. In conclusion, our data show that brain network alterations precede the canonical Aβ protein deposition and that, such alterations can be related to β-CTF fragment.http://journal.frontiersin.org/article/10.3389/fncel.2018.00121/fullAlzheimer’s diseasehippocampusCA1/subiculum areaamyloid-ββ-CTF
spellingShingle Siddhartha Mondragón-Rodríguez
Siddhartha Mondragón-Rodríguez
Siddhartha Mondragón-Rodríguez
Ning Gu
Ning Gu
Frederic Manseau
Sylvain Williams
Alzheimer’s Transgenic Model Is Characterized by Very Early Brain Network Alterations and β-CTF Fragment Accumulation: Reversal by β-Secretase Inhibition
Frontiers in Cellular Neuroscience
Alzheimer’s disease
hippocampus
CA1/subiculum area
amyloid-β
β-CTF
title Alzheimer’s Transgenic Model Is Characterized by Very Early Brain Network Alterations and β-CTF Fragment Accumulation: Reversal by β-Secretase Inhibition
title_full Alzheimer’s Transgenic Model Is Characterized by Very Early Brain Network Alterations and β-CTF Fragment Accumulation: Reversal by β-Secretase Inhibition
title_fullStr Alzheimer’s Transgenic Model Is Characterized by Very Early Brain Network Alterations and β-CTF Fragment Accumulation: Reversal by β-Secretase Inhibition
title_full_unstemmed Alzheimer’s Transgenic Model Is Characterized by Very Early Brain Network Alterations and β-CTF Fragment Accumulation: Reversal by β-Secretase Inhibition
title_short Alzheimer’s Transgenic Model Is Characterized by Very Early Brain Network Alterations and β-CTF Fragment Accumulation: Reversal by β-Secretase Inhibition
title_sort alzheimer s transgenic model is characterized by very early brain network alterations and β ctf fragment accumulation reversal by β secretase inhibition
topic Alzheimer’s disease
hippocampus
CA1/subiculum area
amyloid-β
β-CTF
url http://journal.frontiersin.org/article/10.3389/fncel.2018.00121/full
work_keys_str_mv AT siddharthamondragonrodriguez alzheimerstransgenicmodelischaracterizedbyveryearlybrainnetworkalterationsandbctffragmentaccumulationreversalbybsecretaseinhibition
AT siddharthamondragonrodriguez alzheimerstransgenicmodelischaracterizedbyveryearlybrainnetworkalterationsandbctffragmentaccumulationreversalbybsecretaseinhibition
AT siddharthamondragonrodriguez alzheimerstransgenicmodelischaracterizedbyveryearlybrainnetworkalterationsandbctffragmentaccumulationreversalbybsecretaseinhibition
AT ninggu alzheimerstransgenicmodelischaracterizedbyveryearlybrainnetworkalterationsandbctffragmentaccumulationreversalbybsecretaseinhibition
AT ninggu alzheimerstransgenicmodelischaracterizedbyveryearlybrainnetworkalterationsandbctffragmentaccumulationreversalbybsecretaseinhibition
AT fredericmanseau alzheimerstransgenicmodelischaracterizedbyveryearlybrainnetworkalterationsandbctffragmentaccumulationreversalbybsecretaseinhibition
AT sylvainwilliams alzheimerstransgenicmodelischaracterizedbyveryearlybrainnetworkalterationsandbctffragmentaccumulationreversalbybsecretaseinhibition